|Brand Name (active ingredient)||Disease Area||Region/Country of Approval||Owner|
|Chenodeoxycholic acid Leadiant (chenodeoxycholic acid)||Metabolic||Europe, including Switzerland, Israel, Chile||Leadiant Biosciences Ltd.|
|Natulan (procarbazine hydrochoride)||Oncology||Europe||Leadiant Biosciences Ltd.|
Last update: June 2019
For patients: if you wish to report an adverse event related to one of our products, please contact your healthcare provider. In addition, you can contact us on email@example.com.
For healthcare professionals: if you wish to report an adverse event related to one of our products, please follow the current regulatory procedure in force in your country or contact us at firstname.lastname@example.org.
If your residence is in the U.S. or Canada, please consult the North American website for details on safety reporting.